NES and pulmonary fibrosis: Research shows that this marker is present in pathological conditions as well; for example, nestin contributes to progression of pulmonary fibrosis [46], and hypoxia-induced nestin promotes progression of non-small lung cancer cells by targeting specific transcription factors [47].